RxDoctor Payments Data

Christine Testa

Adult Health · Florissant, MONPI 1013121383

Payments from drug & device makers

$1,522in general payments, 2019–2025

Across 61 payments — averaging $24.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$425
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$212
  • Amgen$207
  • Novartis$199
  • Novo Nordisk$100
  • Boehringer Ingelheim$73
  • plus $306 from 8 others

What the payments were for

  • Food & beverage$1,522100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,522 in reported general payments places this provider in the 65th percentile of 555 adult health providers in Missouri.

See all adult health providers in Missouri

Medicare billing

Part B allowed, 2024
$63,768
Medicare patients
481
Services billed
659

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban85$103,769
XareltoRivaroxaban86$83,778
EntrestoSacubitril/Valsartan56$57,121
FarxigaDapagliflozin Propanediol13$10,269
Metoprolol Succinate135$1,802
Amiodarone Hcl35$1,041
Atorvastatin Calcium110$938
Dilt-XrDiltiazem Hcl17$811
Isosorbide Mononitrate ErIsosorbide Mononitrate54$776
Metoprolol Tartrate100$567
Carvedilol59$550
Potassium Chloride26$461
Nitroglycerin40$460
Furosemide108$419
Ezetimibe19$335

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$425$83,77886 claims
NovartisEntresto$199$57,12156 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 555 adult health providers in Missouri.

Other adult health in Florissant

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →